Skip to main content
Year archive

BerGenBio — 2025 filings

All 34 regulatory filings released by BerGenBio (BGBIO) in 2025, sourced directly from the official regulator.

34 Filings
2025 Period
2025 filings (34)
Filing Released Lang
Merger of BerGenBio and Oncoinvent completed
M&A Activity
2025-10-29 English
BerGenBio and Oncoinvent - Last day of trading in the shares of Oncoinvent
Delisting Announcement
2025-10-29 English
BerGenBio ASA: Approval and publication of prospectus
Capital/Financing Update
2025-10-28 English
BerGenBio and Oncoinvent - Key Dates for Completion of Merger
M&A Activity
2025-10-24 English
BerGenBio ASA: Updated Key Information related to the contemplated Rights Issue
Share Issue/Capital Change
2025-09-17 English
BerGenBio ASA: Updated information regarding the contemplated Rights Issue and Merger
Share Issue/Capital Change
2025-09-17 English
BerGenBio First half results 2025 - Attachment: H1_2025_Financial_report.pdf
Interim / Quarterly Report H1 2025
2025-08-20 English
BerGenBio First half results 2025
Earnings Release H1 2025
2025-08-20 English
BerGenBio ASA - Updated key information related to the rights issue
Share Issue/Capital Change
2025-08-05 English
BerGenBio ASA: Approval of the merger plan and the fully underwritten rights issue - Attachment: EGM_Minutes_04_08_25_BerGenBio_ASA.pdf
Declaration of Voting Results & Voting Rights Announcements
2025-08-04 Norwegian
BerGenBio ASA: Approval of the merger plan and the fully underwritten rights issue
M&A Activity
2025-08-04 English
BerGenBio ASA: Notice of Extraordinary General Meeting - Attachment: BerGenBio_Notice_of_EGM_4_August_2025.pdf
AGM Information
2025-07-03 Norwegian
BerGenBio ASA: Notice of Extraordinary General Meeting
AGM Information
2025-07-03 English
BerGenBio ASA - Key information related to the rights issue
Share Issue/Capital Change
2025-06-30 English
Announcement of fully underwritten rights issue - Attachment: Attachment_overview_of_underwriters.pdf
Share Issue/Capital Change
2025-06-30 English
Announcement of fully underwritten rights issue
Capital/Financing Update
2025-06-30 English
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
M&A Activity
2025-06-30 English
BerGenBio ASA - Minutes from the annual general meeting 2025 - Attachment: BerGenBio_ASA_AGM_minutes_26_June_2025.pdf
AGM Information
2025-06-26 Norwegian
BerGenBio ASA - Minutes from the annual general meeting 2025
AGM Information
2025-06-26 English
BerGenBio ASA: Update on Strategic Review Process and Status of Activities
M&A Activity
2025-06-03 English
BerGenBio ASA: Notice of Annual General Meeting - Attachment: Notice_of_AGM_BerGenBio_ASA_26_June_2025.pdf
AGM Information
2025-06-03 Norwegian
BerGenBio ASA: Notice of Annual General Meeting
AGM Information
2025-06-03 English
Financial calendar
Report Publication Announcement
2025-04-30 English
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar
Annual Report (ESEF) FY 2024
2025-04-29 English
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar
Annual Report FY 2024
2025-04-29 English
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar
Report Publication Announcement
2025-04-29 English
BerGenBio announces Nature Communications Publication of BGBC003 Ph2 data in relapsed/refractory Acute Myeloid Leukemia patients
Regulatory Filings
2025-03-26 English
BerGenBio announces advancement of its strategic review
M&A Activity
2025-03-17 English
BerGenBio Fourth Quarter Results 2024
Interim / Quarterly Report Q4 2024
2025-02-26 English
BerGenBio Fourth Quarter Results 2024
Earnings Release Q4 2024
2025-02-26 English
BerGenBio announces discontinuation of 1L STK11M NSCLC study and exploration of strategic alternatives
Legal Proceedings Report
2025-02-25 English
BerGenBio avslutter 1L STK11m NSCLC-studie og vil utforske strategiske alternativer
Regulatory Filings
2025-02-25 Norwegian
BerGenBio - Disclosure of shareholding
Major Shareholding Notification
2025-02-24 English
BerGenBio ASA: Invitation to fourth quarter 2024 results webcast
Report Publication Announcement
2025-02-18 English